These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 10450837)
1. Overlap of chronic fatigue syndrome with primary adrenocortical insufficiency. Baschetti R Horm Metab Res; 1999 Jul; 31(7):439. PubMed ID: 10450837 [No Abstract] [Full Text] [Related]
2. Chronic fatigue syndrome. Baschetti R N Z Med J; 1999 Jun; 112(1090):242. PubMed ID: 10449006 [No Abstract] [Full Text] [Related]
3. Investigations of hydrocortisone and fludrocortisone in the treatment of chronic fatigue syndrome. Baschetti R J Clin Endocrinol Metab; 1999 Jun; 84(6):2263-4. PubMed ID: 10372750 [No Abstract] [Full Text] [Related]
5. Fludrocortisone and chronic fatigue syndrome. Baschetti R N Z Med J; 2003 Aug; 116(1179):U549. PubMed ID: 14513090 [No Abstract] [Full Text] [Related]
7. Cost-effectiveness of cognitive behaviour therapy for patients with chronic fatigue syndrome. Baschetti R QJM; 2004 Jun; 97(6):378-9. PubMed ID: 15152113 [No Abstract] [Full Text] [Related]
8. Single aetiological agent may not be feasible in CFS patients. Vojdani A J Intern Med; 1999 Apr; 245(4):410-2. PubMed ID: 10356606 [No Abstract] [Full Text] [Related]
9. Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. Wheatland R Med Hypotheses; 2005; 65(2):287-95. PubMed ID: 15885924 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Blockmans D; Persoons P; Van Houdenhove B; Lejeune M; Bobbaers H Am J Med; 2003 Jun; 114(9):736-41. PubMed ID: 12829200 [TBL] [Abstract][Full Text] [Related]